This study intends to determine the number and percent of subjects initially diagnosed with divergence excess exotropia which would be reclassified as simulated divergence excess exotropia if tested after 24 hours of monocular occlusion (patching) or after prism adaptation for the distance angle.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1
The subject will occlude the non-dominant eye for 24 hours.
The subject will undergo prism adaptation targeting the pre-occlusion distance angle for 1-2 weeks. • Fresnel prism(s) will be applied to the patient's spectacles equaling the distance angle between the two eyes. At the examiner's discretion depending on the size of the deviation, the prism(s) can be placed solely over the non-dominant eye, or split between the 2 eyes in some combination which results in equalization of the distance exotropia. If the distance angle calls for an amount of prism that cannot be exactly replicated with Fresnel prisms (e.g., 32 PD), the amount of prism used will be determined by rounding down to the nearest practical amount at examiner discretion.
University of California Los Angeles
Los Angeles, California, United States
Harvard University
Boston, Massachusetts, United States
Ross Eye Institute
Buffalo, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
Percent of participants reclassified as divergence excess exotropia
Percentage of patients with distance and near exotropia measurements within 2.5 prism diopters on alternate prism and cover testing after 24 hours of patching or 7-14 days of fresnel prism use.
Time frame: 2 weeks
Percent of participants reclassified as simulated divergence excess exotropia
Percentage of patients with distance and near exotropia measurements differing by more than 2.5 prism diopters on alternate prism and cover testing after 24 hours of patching or 7-14 days of fresnel prism use.
Time frame: 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Queen's University
Kingston, Ontario, Canada
LV Prasad Eye Institute
Hyderabad, India
Shamir Medical Center
Rishon LeZiyyon, Central District, Israel
University of Milan
Milan, Italy